4613347879

immunosurveillance limits metastatic outgrowth, m a mouse model of melanoma. The Journal of Clinical Investigation 120, 2030-2039.

Fantin, A., Vieira, J.M., Gestri, G., Denti, L., Schwarz, Q., Prykhozhij, S., Peri, F., Wilson, S.W., and Ruhrberg, C. (2010). Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip celi induction. Blood 116, 829-840.

Femandez, M., Porosnicu, M., Markovic, D., and Barber, G.N. (2002). Genetically Engineered Vesicular Stomatitis Virus in Gene Therapy: Application for Treatment of Malignant Disease. J. Virol. 76, 895-904.

Femandez, N.C., Lozier, A., Flament, C., Ricciardi-Castagnoli, P., Bellet, D., Suter, M., Perricaudet, M., Tursz, T., Maraskovsky, E., and Zitvogel, L. (1999). Dendritic cells directly trigger NK celi functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5, 405-411.

Ferran, M., and Lucas-Lenard, J. (1997). The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J. Virol. 7/, 371-377.

Fidler, I.J. (1970). Metastasis: Quantitative analysis of distribution and fate of tumor emboli labeled with 125I-5-Iodo-2' -deoxyuridine. J. Natl. Cancer Inst. 45, 773-782.

Fields, B.N., and Hawkins, K. (1967). Human infection with the virus of Vesicular Stomatitis during an epizootie. N. Engl. J. Med. 277,989-994.

Finkelshtein, D., Werman, A., Novick, D., Barak, S., and Rubinstein, M. (2013) LDL receptor and its family members serve as the cellular receptors for vesicular stomatitis vims. Proceedings of the National Academy of Sciences 110, 7306-7311.

Fishelson, Z., Donin, N., Zell, S., Schultz, S., and Kirschfink, M. (2003). Obstacles to cancer immunotherapy: expression of membranę complement regulatory proteins (mCRPs) in tumors. Mol. Immunol. 40,109-123.

Fitzgerald, K.A., McWhirter, S.M., Faia, K.L., Rowe, D.C., Latz, E, Golenbock, D.T., Coyle, A.J., Liao, S.-M., and Maniatis, T. (2003). IKX[epsilon] and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4, 491-496.

Fleury, D., Barrere, B., Bizebard, T., Daniels, R.S., Skehel, J.J., and Knossow, M. (1999) A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat. Struct. Mol. Biol. 6, 530-534.